Table 1 Clinical and biochemical characteristics of all subjects
Variables | LVH+ N = 420 | LVH− N = 845 | P value |
|---|---|---|---|
Age (years) | 52.5 ± 6.6 | 51.8 ± 8.4 | NS |
Male (n, %) | 67.5% | 68.2% | NS |
Alcohol intake (n, %) | 32.8% | 30.5% | NS |
Smoker (n, %) | 46.7% | 26.4.1% | 0.011 |
BMI (kg/m2) | 24.4 ± 2.2 | 23.8 ± 3.5 | NS |
SBP (mmHg) | 152.9 ± 8.0 | 149.6 ± 11.5 | NS |
DBP (mmHg) | 87.8 ± 7.9 | 89.5 ± 10.6 | NS |
TG (ng/dl) | 5.2 ± 2.8 | 5.1 ± 2.3 | NS |
TC (ng/dl) | 1.6 ± 0.3 | 1.6 ± 0.4 | NS |
HDL-C (ng/dl) | 1.3 ± 0.8 | 1.7 ± 0.5 | NS |
LDL-C (ng/dl) | 2.5 ± 0.8 | 2.6 ± 0.5 | NS |
sCr (mmol/l) | 101.6 ± 11.5 | 90.8 ± 12.7 | NS |
Duration since EH diagnosis (months) | 24.4 ± 3.9 | 23.7 ± 5.2 | NS |
Therapy protocol | |||
ACEI (%) | 36.7 | 35.9 | NS |
Time (month) | 17.7 ± 3.2 | 16.8 ± 4.8 | NS |
ARB (%) | 28.9 | 28.9 | NS |
Time (month) | 12.8 ± 2.2 | 12.4 ± 1.8 | NS |
CCB (%) | 33.2 | 32.6 | NS |
Time (month) | 13.5 ± 3.1 | 13.4 ± 1.9 | NS |
Diuretics (%) | 6.8 | 6.7 | NS |
Time (month) | 8.7 ± 2.1 | 8.8 ± 2.6 | NS |
β-blocker (%) | 23.7 | 24.1 | NS |
Time (month) | 16.2 ± 3.0 | 16.0 ± 2.3 | NS |
Others (%) | 22.7 | 21.8 | NS |
Time (month) | 7.7 ± 1.2 | 7.8 ± 0.9 | NS |